The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy
Open accessAbstract
Different stimuli can polarize macrophages into two basic types, M1 and M2. Tumor-associated macrophages (TAMs) in the tumor microenvironment (TME) are composed of heterogeneous subpopulations, which include the M1 anti-tumor and M2 pro-tumor phenotypes. TAMs predominantly play a M2-like tumor-promoting role in the TME and regulate various malignant effects, such as angiogenesis, immune suppression, and tumor metastasis; hence, TAMs have emerged as a hot topic of research in cancer therapy. This review focuses on three main aspects of TAMs. First, we summarize macrophage polarization along with the effects on the TME. Second, recent advances and challenges in cancer treatment and the role of M2-like TAMs in immune checkpoint blockade and CAR-T cell therapy are emphasized. Finally, factors, such as signaling pathways, associated with TAM polarization and potential strategies for targeting TAM repolarization to the M1 pro-inflammatory phenotype for cancer therapy are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 1×
“1 Differentiation of Macrophages Macrophages are involved in host defense, wound healing, and immune regulation and differentiate into different phenotypes in response to environmental cues (1).”
BackgroundThe chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Macrophage plasticity, polarization, and function in health and disease
Shapouri‐Moghaddam, A., Mohammadian, S., Vazini, H., Taghadosi, M., Esmaeili, S., Mardani, F., Seifi, B., Mohammadi, A., Afshari, J. T., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26429 · Cited by 4,930
The human tumor microbiome is composed of tumor type–specific intracellular bacteria
Nejman, D., Livyatan, I., Fuks, G., Gavert, N., Zwang, Y., Geller, L. T., Rotter-Maskowitz, A., Weiser, R., Mallel, G., Gigi, E., et al. (2020) · Science · doi:10.1126/science.aay9189 · Cited by 2,464
Bagchi, S., Yuan, R., & Engleman, E. G. (2021) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-042020-042741 · Cited by 2,189
Tumor microenvironment and therapeutic response
Wu, T., & Dai, Y. (2017) · Cancer Letters · doi:10.1016/j.canlet.2016.01.043 · Cited by 1,802
Hallmarks of response, resistance, and toxicity to immune checkpoint blockade
Morad, G., Helmink, B. A., Sharma, P., & Wargo, J. A. (2021) · Cell · doi:10.1016/j.cell.2021.09.020 · Cited by 1,648 · cited 2×
“These immune checkpoint-associated therapies, also known as immune checkpoint blockade (ICB) or immune checkpoint inhibitors (ICIs), include targeting and antagonizing cytotoxic Tlymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1), and its ligands (programmed death ligand 1 [PD-L1] and…”
BackgroundHuman chimeric antigen receptor macrophages for cancer immunotherapy
Klichinsky, M., Ruella, M., Shestova, O., Lu, X. M., Best, A., Zeeman, M., Schmierer, M., Gabrusiewicz, K., Anderson, N. R., Petty, N. E., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0462-y · Cited by 1,495
Macrophage Polarization in Bacterial Infections
Benoit, M., Desnues, B., & Mege, J.-L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.3733 · Cited by 1,329
Mechanisms and consequences of Jak–STAT signaling in the immune system
Villarino, A. V., Kanno, Y., & O'Shea, J. J. (2017) · Nature Immunology · doi:10.1038/ni.3691 · Cited by 1,221
Macrophage Immunometabolism: Where Are We (Going)?
Van den Bossche, J., O’Neill, L. A., & Menon, D. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.03.001 · Cited by 1,163
The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation
Wang, P., Xue, Y., Han, Y., Lin, L., Wu, C., Xu, S., Jiang, Z., Xu, J., Liu, Q., & Cao, X. (2014) · Science · doi:10.1126/science.1251456 · Cited by 1,105
Recent advances and discoveries in the mechanisms and functions of CAR T cells
Larson, R. C., & Maus, M. V. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00323-z · Cited by 852
Macrophage-Based Approaches for Cancer Immunotherapy
Anderson, N. R., Minutolo, N. G., Gill, S., & Klichinsky, M. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2990 · Cited by 698
Macrophage phenotypes in atherosclerosis
Colin, S., Chinetti‐Gbaguidi, G., & Staels, B. (2014) · Immunological Reviews · doi:10.1111/imr.12218 · Cited by 657
Yang, H., Zhang, Q., Xu, M., Wang, L., Chen, X., Feng, Y., Li, Y., Zhang, X., Cui, W., & Jia, X. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01165-x · Cited by 440
Self-citationTumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages
Bohn, T., Rapp, S., Luther, N., Klein, M., Bruehl, T.-J., Kojima, N., Aranda Lopez, P., Hahlbrock, J., Muth, S., Endo, S., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0226-8 · Cited by 436
The roles of tumor-associated macrophages in tumor angiogenesis and metastasis
Fu, L.-Q., Du, W.-L., Cai, M.-H., Yao, J.-Y., Zhao, Y.-Y., & Mou, X.-Z. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104119 · Cited by 415
Heme oxygenase-1 and anti-inflammatory M2 macrophages
Naito, Y., Takagi, T., & Higashimura, Y. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.09.005 · Cited by 360
Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24
Yu, T., Gan, S., Zhu, Q., Dai, D., Li, N., Wang, H., Chen, X., Hou, D., Wang, Y., Pan, Q., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12384-2 · Cited by 348
Rodriguez-Garcia, A., Lynn, R. C., Poussin, M., Eiva, M. A., Shaw, L. C., O’Connor, R. S., Minutolo, N. G., Casado-Medrano, V., Lopez, G., Matsuyama, T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-20893-2 · Cited by 341
Iron overloaded polarizes macrophage to proinflammation phenotype through ROS/acetyl‐p53 pathway
Zhou, Y., Que, K., Zhang, Z., Yi, Z. J., Zhao, P. X., You, Y., Gong, J., & Liu, Z. (2018) · Cancer Medicine · doi:10.1002/cam4.1670 · Cited by 336
Zhang, M., Hutter, G., Kahn, S. A., Azad, T. D., Gholamin, S., Xu, C. Y., Liu, J., Achrol, A. S., Richard, C., Sommerkamp, P., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153550 · Cited by 330
CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges
Bagley, S. J., Desai, A. S., Linette, G. P., June, C. H., & O’Rourke, D. M. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy032 · Cited by 312
The hypoxia–lactate axis tempers inflammation
Ivashkiv, L. B. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0259-8 · Cited by 305
Shao, J., Zaro, J., & Shen, Y. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s281890 · Cited by 295
Nakao, S., Kuwano, T., Tsutsumi-Miyahara, C., Ueda, S.-I., Kimura, Y. N., Hamano, S., Sonoda, K.-H., Saijo, Y., Nukiwa, T., Strieter, R. M., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23298 · Cited by 286
S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β
Weichand, B., Popp, R., Dziumbla, S., Mora, J., Strack, E., Elwakeel, E., Frank, A.-C., Scholich, K., Pierre, S., Syed, S. N., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20160392 · Cited by 267
Wei, B., Pan, J., Yuan, R., Shao, B., Wang, Y., Guo, X., & Zhou, S. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c00209 · Cited by 265
Xiao, M., Zhang, J., Chen, W., & Chen, W. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0815-2 · Cited by 256
Fang, W., Zhou, T., Shi, H., Yao, M., Zhang, D., Qian, H., Zeng, Q., Wang, Y., Jin, F., Chai, C., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01786-6 · Cited by 256
Hwang, I., Kim, J. W., Ylaya, K., Chung, E. J., Kitano, H., Perry, C., Hanaoka, J., Fukuoka, J., Chung, J.-Y., & Hewitt, S. M. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02618-z · Cited by 253
Regulation of macrophage function in tumors: the multifaceted role of NF-κB
Hagemann, T., Biswas, S. K., Lawrence, T., Sica, A., & Lewis, C. E. (2009) · Blood · doi:10.1182/blood-2008-12-172825 · Cited by 248
La Fleur, L., Botling, J., He, F., Pelicano, C., Zhou, C., He, C., Palano, G., Mezheyeuski, A., Micke, P., Ravetch, J. V., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1885 · Cited by 224
Li, M., Li, M., Yang, Y., Liu, Y., Xie, H., Yu, Q., Tian, L., Tang, X., Ren, K., Li, J., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.011 · Cited by 221
Iron alters macrophage polarization status and leads to steatohepatitis and fibrogenesis
Handa, P., Thomas, S., Morgan-Stevenson, V., Maliken, B. D., Gochanour, E., Boukhar, S., Yeh, M. M., & Kowdley, K. V. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.3a0318-108r · Cited by 217
Zhang, A., Xu, Y., Xu, H., Ren, J., Meng, T., Ni, Y., Zhu, Q., Zhang, W.-B., Pan, Y.-B., Jin, J., et al. (2021) · Theranostics · doi:10.7150/thno.53749 · Cited by 209
Immunotherapy for Glioblastoma: Current Progress and Challenges
Yu, M. W., & Quail, D. F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.676301 · Cited by 185
Progress on Modulating Tumor‐Associated Macrophages with Biomaterials
Sylvestre, M., Crane, C. A., & Pun, S. H. (2020) · Advanced Materials · doi:10.1002/adma.201902007 · Cited by 180
Zhang, M., Huang, L., Ding, G., Huang, H., Cao, G., Sun, X., Lou, N., Wei, Q., Shen, T., Xu, X., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000308 · Cited by 172
Arnold, J. N., Magiera, L., Kraman, M., & Fearon, D. T. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0150 · Cited by 166
Xun, J., Du, L., Gao, R., Shen, L., Wang, D., Kang, L., Chen, C., Zhang, Z., Zhang, Y., Yue, S., et al. (2021) · Theranostics · doi:10.7150/thno.51864 · Cited by 160
PGE2-Driven Induction and Maintenance of Cancer-Associated Myeloid-Derived Suppressor Cells
Obermajer, N., Wong, J. L., Edwards, R. P., Odunsi, K. O., Moysich, K. B., & Kaliński, P. (2012) · Immunological Investigations · doi:10.3109/08820139.2012.695417 · Cited by 155
Lu, C.-S., Shiau, A., Su, B., Hsu, T.-S., Wang, C.-T., Su, Y., Tsai, M.-S., Feng, Y., Tseng, Y., Yen, Y., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00887-1 · Cited by 148
Zhong, Q., Fang, Y., Lai, Q., Wang, S., He, C., Li, A., Liu, S., & Yan, Q. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01637-4 · Cited by 148
The Tumor Microbiome in Pancreatic Cancer: Bacteria and Beyond
McAllister, F. M., Khan, M. A. W., Helmink, B. A., & Wargo, J. A. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.11.004 · Cited by 146
Liu, L., Wang, Y., Guo, X., Zhao, J., & Zhou, S. (2020) · Small · doi:10.1002/smll.202003543 · Cited by 136
Targeting tumor-associated macrophages for cancer immunotherapy
Shu, Y., & Cheng, P. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188434 · Cited by 133
Gu, Z., Liu, T., Liu, C., Yang, Y., Tang, J., Song, H., Wang, Y., Yang, Y., & Yu, C. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c01401 · Cited by 133
Koh, Y., Yang, G., Lai, C., Weerawatanakorn, M., & Pan, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082208 · Cited by 131
Lipid accumulation in macrophages confers protumorigenic polarization and immunity in gastric cancer
Luo, Q., Zheng, N., Jiang, L., Wang, T., Zhang, P., Liu, Y., Zheng, P., Wang, W., Xie, G., Chen, L., et al. (2020) · Cancer Science · doi:10.1111/cas.14616 · Cited by 126 · cited 2×
“Furthermore, upon interaction with other factors, such as progranulin (PGRN) and lipid accumulation, TAMs can suppress immune responses with PD-L1 overexpression (32, 33).”
BackgroundTao, S., Chen, Q., Chen, L., & Dong, H. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01676-x · Cited by 116
Engineering macrophages to phagocytose cancer cells by blocking the CD47/SIRPɑ axis
Yang, H., Shao, R., Huang, H., Wang, X., Rong, Z., & Lin, Y. (2019) · Cancer Medicine · doi:10.1002/cam4.2332 · Cited by 112
CD68+HLA-DR+ M1-like macrophages promote motility of HCC cells via NF-κB/FAK pathway
Wang, H., Wang, X., Li, X., Fan, Y., Li, G., Guo, C., Zhu, F., Zhang, L., & Shi, Y. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.11.013 · Cited by 111
Sa, J. K., Chang, N., Lee, H. W., Cho, H. J., Ceccarelli, M., Cerulo, L., Yin, J., Kim, S. S., Caruso, F. P., Lee, M., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02140-x · Cited by 109
Jia, X., Yu, F., Wang, J., Iwanowycz, S., Saaoud, F., Wang, Y., Hu, J., Wang, Q., & Fan, D. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3164-7 · Cited by 104
Mukherjee, S., Fried, A., Hussaini, R., White, R., Baidoo, J., Yalamanchi, S., & Banerjee, P. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0792-5 · Cited by 103
Metal–Organic Framework Nanoparticles for Ameliorating Breast Cancer-Associated Osteolysis
Pang, Y., Fu, Y., Li, C., Wu, Z., Cao, W., Hu, X., Sun, X., He, W., Cao, X., Ling, D., et al. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b02916 · Cited by 101
Tackling TAMs for Cancer Immunotherapy: It’s Nano Time
Yang, Y., Guo, J., & Huang, L. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.08.003 · Cited by 101
Lizotte, P. H., Baird, J. R., Stevens, C. A., Lauer, P., Green, W. R., Brockstedt, D. G., & Fiering, S. (2014) · OncoImmunology · doi:10.4161/onci.28926 · Cited by 89
From immune checkpoints to vaccines: The past, present and future of cancer immunotherapy
Osipov, A., Murphy, A. G., & Zheng, L. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.002 · Cited by 77
A Stat1 bound enhancer promotes Nampt expression and function within tumor associated macrophages
Huffaker, T. B., Ekiz, H. A., Barba, C., Lee, S.-H., Runtsch, M. C., Nelson, M. C., Bauer, K. M., Tang, W. W., Mosbruger, T. L., Cox, J. E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22923-5 · Cited by 76
“Re-educating” Tumor Associated Macrophages as a Novel Immunotherapy Strategy for Neuroblastoma
Liu, K. X., & Joshi, S. S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01947 · Cited by 74
Wu, H., Zhang, X., Han, D., Cao, J., & Tian, J. (2020) · PeerJ · doi:10.7717/peerj.8721 · Cited by 72
Exosomes: A Potential Therapeutic Tool Targeting Communications between Tumor Cells and Macrophages
Guo, W., Li, Y., Pang, W., & Shen, H. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.06.003 · Cited by 70
Xu, D., Wang, Y., Wu, J., Zhang, Z., Chen, J., Xie, M., Tang, R., Chen, C., Chen, L., Lin, S., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03450-z · Cited by 66
Fujimoto, J., Aoki, I., Khatun, S., Toyoki, H., & Tamaya, T. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf078 · Cited by 63
Chen, Y., Bi, L., Luo, H., Jiang, Y., Chen, F., Wang, Y., Wei, G., & Chen, W. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.12.003 · Cited by 59
Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages
Martile, M. D., Farini, V., Consonni, F. M., Trisciuoglio, D., Desideri, M., Valentini, E., D’Aguanno, S., Tupone, M. G., Buglioni, S., Ercolani, C., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000489 · Cited by 50
Carvalho, M. I., Pires, I. C. R., Prada, J., Raposo, T. P., Gregório, H., Lobo, L., & QUEIROGA, F. L. (2016) · Veterinary and Comparative Oncology · doi:10.1111/vco.12206 · Cited by 49
Le, K., Sun, J. P., Khawaja, H., Shibata, M., Maggirwar, S. B., Smith, M. R., & Gupta, M. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003871 · Cited by 38
Santoni, M., Massari, F., Montironi, R., & Battelli, N. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188547 · Cited by 30
Kim, S. H., Saeidi, S., Zhong, X., Gwak, S.-Y., Muna, I. A., Park, S., Kim, S. H., Na, H., Joe, Y., Chung, H., et al. (2020) · Neoplasia · doi:10.1016/j.neo.2020.08.006 · Cited by 28
Wang, Z., Zhao, Y., Xu, H., Liang, F., Zou, Q., Wang, C., Jiang, J., & Lin, F. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15751 · Cited by 26
NSE from diffuse large B-cell lymphoma cells regulates macrophage polarization
Zhu, M.-Y., Liu, W.-J., Wang, H., Wang, W.-D., Liu, N.-W., & Lu, Y. (2019) · Cancer Management and Research · doi:10.2147/cmar.s203010 · Cited by 23
Cited by
Macrophage polarization: an important role in inflammatory diseases
Luo, M., Zhao, F., Cheng, H., Su, M., & Wang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1352946 · Cited by 468
Unveiling the mechanisms and challenges of cancer drug resistance
Khan, S. U., Fatima, K., Aisha, S., & Malik, F. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01302-1 · Cited by 417
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Lu, Q., Kou, D., Lou, S., Ashrafizadeh, M., Aref, A. R., Canadas, I., Tian, Y., Niu, X., Wang, Y., Torabian, P., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01535-8 · Cited by 373
Self-citationMacrophage plasticity: signaling pathways, tissue repair, and regeneration
Yan, L., Wang, J., Cai, X., Liou, Y., Shen, H., Hao, J., Huang, C., Luo, G., & He, W. (2024) · MedComm · doi:10.1002/mco2.658 · Cited by 343
The role of tumor-associated macrophages in tumor immune evasion
Huang, R., Kang, T., & Chen, S. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05777-4 · Cited by 230
Metadata
- Authors
- Gao, J., Liang, Y., & Wang, L.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2022-06-30
- Volume
- 13
- Pages
- 888713-888713
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W4283714737
- Cited by
- 555
- References
- 75
- FWCI
- 33.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.